Correlation Between Kilitch Drugs and India Glycols

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kilitch Drugs and India Glycols at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kilitch Drugs and India Glycols into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kilitch Drugs Limited and India Glycols Limited, you can compare the effects of market volatilities on Kilitch Drugs and India Glycols and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kilitch Drugs with a short position of India Glycols. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kilitch Drugs and India Glycols.

Diversification Opportunities for Kilitch Drugs and India Glycols

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Kilitch and India is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Kilitch Drugs Limited and India Glycols Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on India Glycols Limited and Kilitch Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kilitch Drugs Limited are associated (or correlated) with India Glycols. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of India Glycols Limited has no effect on the direction of Kilitch Drugs i.e., Kilitch Drugs and India Glycols go up and down completely randomly.

Pair Corralation between Kilitch Drugs and India Glycols

Assuming the 90 days trading horizon Kilitch Drugs is expected to generate 5.14 times less return on investment than India Glycols. But when comparing it to its historical volatility, Kilitch Drugs Limited is 1.08 times less risky than India Glycols. It trades about 0.02 of its potential returns per unit of risk. India Glycols Limited is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  70,005  in India Glycols Limited on September 1, 2024 and sell it today you would earn a total of  57,590  from holding India Glycols Limited or generate 82.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.62%
ValuesDaily Returns

Kilitch Drugs Limited  vs.  India Glycols Limited

 Performance 
       Timeline  
Kilitch Drugs Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kilitch Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Kilitch Drugs is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.
India Glycols Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days India Glycols Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, India Glycols is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Kilitch Drugs and India Glycols Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kilitch Drugs and India Glycols

The main advantage of trading using opposite Kilitch Drugs and India Glycols positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kilitch Drugs position performs unexpectedly, India Glycols can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in India Glycols will offset losses from the drop in India Glycols' long position.
The idea behind Kilitch Drugs Limited and India Glycols Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.